(No ratings)
Dr. Karine Tawagi, MD is a medical oncologist in Chicago, IL specializing in medical oncology, adult oncology and adult hematology. She graduated from St. George's University School of Medicine. Dr. Karine Tawagi, MD is affiliated with University of Illinois Hospital & Health Sciences System (UI Health) and THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS.
1801 W Taylor Street Suite 1e
Chicago, IL 60612
1818 W. Taylor Street Suite 1e
Chicago, IL 60612
Dr. Karine Tawagi, MD graduated from St. George's University School of Medicine. She completed residency at St. Joseph Mercy Ann Arbor. She is certified by the American Board of Internal Medicine (Hematology, Medical Oncology) and has a state license in Illinois.
Medical School: St. George's University School of Medicine
Residency: St. Joseph Mercy Ann Arbor
Board Certification: American Board of Internal Medicine (Hematology, Medical Oncology)
Licensed In: Illinois
Dr. Karine Tawagi, MD is associated with these hospitals and organizations:
Dr. Karine Tawagi, MD does not have any reviews yet, be the first to leave a review of Dr. Karine Tawagi, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Karine Tawagi, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
E.R. Squibb & Sons, L.L.C. |
$338
OPDIVO $338 |
|||||
---|---|---|---|---|---|---|
Merck Sharp & Dohme Corporation |
$334
KEYTRUDA $298 |
Lenvima $19 |
LYNPARZA $17 |
|||
Jazz Pharmaceuticals Inc. |
$259
VYXEOS $259 |
|||||
Amgen Inc. |
$195
$195 |
|||||
Dendreon Pharmaceuticals LLC |
$139
PROVENGE $139 |
|||||
Other |
$648
ZEJULA $122 |
Rubraca $121 |
Lenvima $99 |
IMBRUVICA $99 |
NINLARO $88 |
Other $119 |
Food and Beverage | $1,543 |
---|---|
Education | $370 |
Dr. Karine Tawagi's areas of specialization are adult hematology, adult oncology, and medical oncology; she sees patients in Chicago, IL. She is conversant in French. Her clinical interests include bladder cancer, kidney cancer, and prostate cancer. Dr. Tawagi is affiliated with the University of Illinois Hospital & Health Sciences System (UI Health). Dr. Tawagi attended St. George's University School of Medicine and subsequently trained at St. Joseph Mercy Ann Arbor for residency.